BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22581873)

  • 1. The cost of managing genital warts in the UK.
    Lanitis T; Carroll S; O'Mahony C; Charman F; Khalid JM; Griffiths V; Brown RE
    Int J STD AIDS; 2012 Mar; 23(3):189-94. PubMed ID: 22581873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The costs of managing genital warts in the UK by devolved nation: England, Scotland, Wales and Northern Ireland.
    Coles VA; Chapman R; Lanitis T; Carroll SM
    Int J STD AIDS; 2016 Jan; 27(1):51-7. PubMed ID: 25681263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK.
    Brown RE; Breugelmans JG; Theodoratou D; Bénard S
    Curr Med Res Opin; 2006 Apr; 22(4):663-70. PubMed ID: 16684427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination.
    Östensson E; Fröberg M; Leval A; Hellström AC; Bäcklund M; Zethraeus N; Andersson S
    PLoS One; 2015; 10(9):e0139062. PubMed ID: 26398189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genital warts and cost of care in England.
    Desai S; Wetten S; Woodhall SC; Peters L; Hughes G; Soldan K
    Sex Transm Infect; 2011 Oct; 87(6):464-8. PubMed ID: 21813567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment patterns and associated costs for genital warts in Italy.
    Merito M; Largeron N; Cohet C; Timelli L; Boselli F; Matteelli A; Naldi L; Vittori G
    Curr Med Res Opin; 2008 Nov; 24(11):3175-83. PubMed ID: 18851777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of treatment and QALYs lost due to genital warts: data for the economic evaluation of HPV vaccines in the United Kingdom.
    Woodhall SC; Jit M; Cai C; Ramsey T; Zia S; Crouch S; Birks Y; Newton R; Edmunds WJ; Lacey CJ
    Sex Transm Dis; 2009 Aug; 36(8):515-21. PubMed ID: 19543143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The health and economic burden of genital warts in a set of private health plans in the United States.
    Insinga RP; Dasbach EJ; Myers ER
    Clin Infect Dis; 2003 Jun; 36(11):1397-403. PubMed ID: 12766834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of genital warts: loss of quality of life and cost of treatment in eight sexual health clinics in the UK.
    Woodhall SC; Jit M; Soldan K; Kinghorn G; Gilson R; Nathan M; Ross JD; Lacey CJ;
    Sex Transm Infect; 2011 Oct; 87(6):458-63. PubMed ID: 21636616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The costs of treating external genital warts in England and Wales: a treatment pattern analysis.
    Langley PC; White DJ; Drake SM
    Int J STD AIDS; 2004 Aug; 15(8):501-8. PubMed ID: 15307958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in Belgium.
    Annemans L; Rémy V; Lamure E; Spaepen E; Lamotte M; Muchada JP; Largeron N
    J Med Econ; 2008; 11(1):135-50. PubMed ID: 19450115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross-sectional study estimating the burden of illness related to genital warts in South Korea.
    Lee TS; Kothari-Talwar S; Singhal PK; Yee K; Kulkarni A; Lara N; Roset M; Giuliano AR; Garland SM; Ju W
    BMJ Open; 2017 Jul; 7(6):e014217. PubMed ID: 28674130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining the cost of genital warts: a study from Ireland.
    Dee A; Howell F; O'Connor C; Cremin S; Hunter K
    Sex Transm Infect; 2009 Sep; 85(5):402-3. PubMed ID: 19004863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective analysis of the costs and management of genital warts in Italy.
    Gianino MM; Delmonte S; Lovato E; Martinese M; Rondoletti S; Bernengo MG; Zotti CM
    BMC Infect Dis; 2013 Oct; 13():470. PubMed ID: 24106891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, psychosocial burden, and economic impact of genital warts in Mexico.
    Domenech-Viñolas M; León-Maldonado L; Ramírez-Palacios P; Flores YN; Granados-García V; Brown B; Corona E; Liu S; Lazcano-Ponce E; Salmerón J
    Salud Publica Mex; 2018; 60(6):624-632. PubMed ID: 30699267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and costs associated with genital warts in Canada.
    Marra F; Ogilvie G; Colley L; Kliewer E; Marra CA
    Sex Transm Infect; 2009 Apr; 85(2):111-5. PubMed ID: 18981170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genital warts incidence and healthcare resource utilisation in Australia.
    Pirotta M; Stein AN; Conway EL; Harrison C; Britt H; Garland S
    Sex Transm Infect; 2010 Jun; 86(3):181-6. PubMed ID: 19965802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective analysis of costs and patterns of treatment for external genital warts in The Netherlands.
    van der Meijden WI; Notowicz A; Blog FB; Langley PC
    Clin Ther; 2002 Jan; 24(1):183-96. PubMed ID: 11833831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and cost of treatment of genital warts in Spain.
    Castellsagué X; Cohet C; Puig-Tintoré LM; Acebes LO; Salinas J; San Martin M; Breitscheidel L; Rémy V
    Eur J Public Health; 2009 Jan; 19(1):106-10. PubMed ID: 19112075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing incidence and economic burden of genital warts with data from a US commercially insured population.
    Hoy T; Singhal PK; Willey VJ; Insinga RP
    Curr Med Res Opin; 2009 Oct; 25(10):2343-51. PubMed ID: 19650749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.